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Summary.-The ability of s.c. injected tumour cells to specifically inhibit the growth
of similar cells injected i.v. 2 days later has been confirmed. The capacity of tumour
cells to elicit this effect varies from tumour to tumour. Furthermore, it is more
readily achieved with cultured than with freshly excised tumour cells. The superior
effect elicited by cultured tumour cells was not overcome by treating them with
trypsin or pronase. The protection achieved was impaired in T-cell-depleted mice
and mice which had been irradiated (400 rad) prior to pretreatment. In contrast, it
was not affected by administration of silica, sodium aurothiomolate or cortisone
acetate. The results imply that T-cell-dependent responses are involved in the
protection conferred by pre-injecting tumour cells shortly before i.v. challenge.
RECENTLY, we reported that the pre-
injection (s.c.) of syngeneic methylcholan-
threne-induced fibrosarcoma cells inhibit-
ed the growth of homologous tumour in-
jected i.v. 1 or 2 days later. This effect,
however, was not observed if the s.c. in-
jection was delayed until one day after
tumour challenge. In addition, this pre-
treatment frequently enhanced the cyto-
static effect of peritoneal-exudate cells on
tumour-cell monolayers (James et al.,
1978). These observations were somewhat
unexpected, in view of the many reports
then appearing, suggesting that trans-
planted tumours might promptly release
products which could impair the host
response against themselves, so permitting
the tumour to escape surveillance (re-
viewed in James, 1977).
In view of the effectiveness of the pro-
tection observed and the rapidity with
which it was achieved, we decided this
phenomenon was worth further investiga-
tion. The present report summarizes the
results of studies undertaken; (a) to estab-
lish more conclusively the specificity ofthe
effect, (b) to compare the protection con-
ferred by tumour-cell inocula prepared in
various ways, and (c) to ascertain the
possible immunological mechanisms in-
volved.
MATERIALS AND METHODS
Mice.-All the investigations were per-
formed in inbred CBA/Ca male mice age 10-12
weeks. These mice were bred from stock
supplied by the MRC Laboratory Animals
Centre, Carshalton, Surrey.
T-cell-deprived mice were prepared by
thymectomizing 5-week-old mice and sub-
jecting them 1 week later to 800 rad whole-
body irradiation with thorax shielding. About
7 weeks later the animals were used. The
immune status of the T-cell-deprived mice
was routinely assessed by challenging them
i.p. with 3 x 108 sheep erythrocytes and de-
termining 7-9 days later the levels of circu-
lating antibodies (both sensitive and resistant
to mereaptoethanol) by standard passive
haemagglutination techniques. The mice were
also checked at the time ofsacrifice for thymic
remnants.
In certain instances, the mice were also
subject to 400 rad whole-body X-irradiation
with thorax shielding. A Westinghouse X-ray
machine with the following physical condi-
tions was used throughout for X-irradiation:
230 kV, 15 mA, with 0 5 mm Cu and 100
mm Al filters, a target-to-object distance of
75 cm and a delivery rate of 60 rad/min.123 PROTECTION AGAINST SYNGENEIC TUMOUR CELLS
TABLEI.-Some chai-acteri-stic-s of the -syngeneic tumoui-s u8ed in the present -study
Generation
Nos.*
2 1
Tumotir
designation
CCHI
CCH5
T3
TD50T
27
830
57
ND
Description
Fibrosarcoma
Fibrosarcoma
Fibrosarcoma
How 111(luce(I TImmunogenicityt
105-106
105
104
< 104
or 22 3 met,hyleholanthrene
3 3 methylcholanthrene
By transplantation of
embryo cells spontaneously
transformed hi vitro
15 Spoiitaneotis W54 Adenocai-einoma
* Prior to transplantation oi- establishment in tissue culture. T3 was maintained in culture throughout.
t The challenge dose against which the preiiijection of 106 irradiate(i tumour cells 2 weeks earlier affects
complete protectioll.
I The number of tumour cells which when injecte(I s.e. gives rise to tumours in 50% of the mice.
Tumom-,,..-The syngeneic tumours used
included two MC-induced fibrosarcomas (de-
signated CCHI and CCH5), a spontaneous
adenocareinoma (AA754) and a fibrosarcoma
(T3) which had been obtained after iiijection
of CBA mice with syngeneic embryo cells
which had undergone spontaneous transfor-
ination in vitro. Further details on these
tumours are in Table I and elsewhere (James
et al., 1978; Woodruff et al., 1978). Cultured
tumour cells Nx-ere geiierally used for pretreat-
ment and challenge. These cells liad been
maintained in culture for varying periods of
time, under conditions previously described
by Ghaffar et al., (1974). The culture line was
routinely examined for viral conta' ination,
as previously described (James et ttl., 1978)
and shown to be free of viruses and other
micro-organisms.
The tumour cells Aere generally harvested
from the culture flasks by incubating the
washed tumour-cell monolayers in Dulbecco
A containing 0-2% (w/v) EDTA for 10 min.
On certain occasions (see later) the cells were
harvested by incubating for 3-5 miii in Dul-
becco/EDTA contaiiiing 0-5 mg/ml trypsin
(Koch-Light, Colnebrook, England) -%Nhilst
on other occasions cells recovered without the
aid oftrypsin iiere subjected to further treat-
ment with pronase for 20 min at 37'C. The
conditions used for treatnient of the cultured
tumour cells -,Nere similar to those used in pre-
paring tumour-cell suspensions from freslily
excised tumours, apart from the omission of
treatment withdeoxyribonuclease (see Wood-
ruff & Boak, 1966).
Other niaterials.-The silica (Dorentrup
Quartz Nr 12 1-5 .um) was sterilized by dry
heating at NOT for 2 h. It was thensuspend-
ed in sterile 0-15m saline and vigorously
mixed before injection. The cortisone acetate
(Glaxo Pharmaceuticals, Ltd, Greenford,
9
England) was suspended at a concentration
of 12-5 mg/ml in sterile 0-15m saline. Finally
the sodium aurothiomalate (Myochrysine,
45% metallic gold; May and Baker Ltd,
Dagenham) was diluted with sterile 0-15m
saline to a conceiitration of 10mg/ml.
In vivo experimental model.-The basic
protocol involved injecting mice s.e. '",ith 106
syngeneic tumour cells 2 days before i.v.
challenge with homologous tumour or other
syngeneic tumours. The mice were killed 14
days after challenge, the lungs removed and
fixed in Bouin's solution and the number of
tumour nodules per lung counted. Each
experimental group initially contained a
minimum of 8 inice. Further experimental
details are recorded elsewhere in the text or
in the footnotes to tables and figures.
Pre8entation of re8ult8.-The number of
tumour nodules observed in the lungs of in-
dividual mice has been presented in scatter-
gram or tabular form and the significance of
the results has been determined by the
Wilcoxon Rank-Sum test. 17alues ofP<0-05
,%A,ere regarded as significant.
RESULTS
Specificity Of 8hort-termprotection
Our initial studies suggested that sig-
nificant inhibition of the growth of i.v.
administered CCHI tumour cells could
only be achieved by the pre-injection of
homologous tumour cells, other syngeneic
and allogeneic tumours exerting little, if
any, effect. The present experiments were
performed to see whetlier specific protec-
tion could also be achievedinothertumour
models. The results of these studies are
presented in Figs. I and 2.K. JAMES, I. MILNE, J. MERRIMAN AND W. H. MCBRIDE
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FIG. 1. The effect on the growth of i.v.
injected MC fibrosarcoma CCH5 of the pre-
injection of various syngeneic tumour cells.
Mice injected s.c. with 106 cultured
tumour cells on Day -2 and challenged
i.v. on Day 0 with 5 x 104 cultured CCH5
tumour cells. 14 days after challenge the
only significant reduction (P<0 01) was
seen in mice pretreated with homologous
tumour. Pretreatment: A No pretreat-
ment; B CCH1; C CCH5; D T3; D-
W54.
It will be observed from Fig. 1 that the
lung-colonizing ability of i.v. injected
CCH5 tumour cells was severely impaired
by the s.c. injection of 106 CCH5 cells 2
days prior to i.v. challenge. The pre-
injection of other syngeneic tumour cells
was without effect, thus confirming and
extending our previous specificity studies
with CCIHI tumour (James et al., 1978).
However, additional studies revealed
that the effect observed is not universal,
for certain tumours (at least at the doses
used) were not able to elicit a protective
effect in this short-term pre-treatment
model. This is illustrated in Fig. 2, where
it can be seen that the s.c. injection of 106
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FIG. 2. The effect on the growth of i.v. in-
jected T3 of the preinjection of various
syngeneic tumour cells. Mice injected s.c.
with 106 cultured tumour cells on Day- 2
and challenged on Day 0 with 5 x 104 cul-
tured T3 cells. None of the pretreatments
significantly inhibited lung tumour nodule
formation. Pretreatment as in legend for
Fig. 1.
T3 tumour cells failed to inhibit thegrowth
of T3 tumour injected i.v. 2 days later.
A comparison of the protection achieved by
tumour-cell suspensionsprocessed in various
ways
An overall analysis of the data obtained
in our original studies indicated that while
a highly reproducible protection could be
achieved after short-term pre-treatment
with cultured tumour cells, a somewhat
inconsistent effect was seen after the pre-
injection of tumour-cell suspensions ob-
tained by pronase digestion of freshly
excised tumour cells (James et al., 1978).
We decided, therefore, to compare directly
the ability of both cultured and freshly
excised tumour cells to inhibit tumour
nodule formation after challenge with
n-
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FIG. 3.-The effects on the growth of i.v.
injected CCH1 tumour cells ofthe preinjec-
tion of cultured or freshly excised homolo-
gous tumour. Mice injected s.c. with 106
cultured or freshly excised tumour cells on
Day -2 and challenged i.v. on Day 0 with
5 x 104 cultured or freshly excised tumour
cells. Preinjection of cultured cells signifi-
cantly inhibited (P<0-01) tumour zodule
formation as measured 14 days after i.v.
challenge with either tumour cell prepara-
tion, while the freshly excised preparation
had no effect. Observe also the superior
lung-colonizing properties of the freshly
excised cells. Pretreatment: A and C No
pretreatment; B and D Cultured cells;
C and F-Freshly excised cells.
either cultured or freshly excised tumour
cells.
It will be seen from Fig. 3 that the lung-
colonizing ability offreshly excisedtumour
cells was superior to that of cultured
tumour cells. In addition, the tumours
resulting from s.c. pre-treatment with
freshly excised cells were larger (mean
diam. 15-2 mm) than those after s.c.
transplantation of cultured tumour cells
(mean diam. 128 mnm). Nevertheless, it is
also readily apparent that cultured cells
alone were capable ofsignificantly inhibit-
ing (P<0 01) tumour-nodule formation
after i.v. challenge with either freshly
excised or cultured tumour cells.
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FIG. 4. A comparison oftheprotectiveeffects
achieved by the preinjection of enzyme-
treated and untreated cultured tumour
cells and foetal calf serum. Mice were in-
jected s.c. on Day -2 with 106 enzyme-
treated or untreated cultured CCH1 tu-
mour cells or 0-1 ml of 10% (w/v) foetal
calf serum, and challenged i.v. with 5 x 104
CCH1 tumour cells on Day 0. Both un-
treated and enzyme-treated cultured tu-
mour cells significantly impaired tumour
nodule formation, whereas the preinjection
of foetal calf serum was without effect.
Pretreatment: A-RPMI; B-RPMI plus
FCS; C-Untreated tumour cells; D-
Trypsin-treated tumour cells; E Pronase-
treated tumour cells.
Additionalexperimentswereundertaken
to ascertain whether the superior protec-
tive effect obtained with cultured cells
might be reduced by submitting these cells
to a similar enzyme treatment to that used
in the preparation of tumour-cell suspen-
sions from freshly excised tumours, a pro-
cedure which undoubtedly removes certainK. JAMES, I. MILNE, J. MERRIMAN AND W. H. MCBRIDE
cell-surface antigens. These studies re-
vealed that both pronase- and trypsin-
treated cultured cells were as effective as
non-enzyme-treated cultured tumour cells
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FiG. 5.-The effect of silica treatment on the
protection achieved by preinjecting tumour
cells 2 days before i.v. challenge. Mice were
injected daily on Days -4 to 0 with either
0-2 ml ofphysiological saline (Groups A and
B) or 0-2 ml of saline containing 2-5 mg
silica (Groups C and D). These injections
were given by both the i.p. (Days -4, -2
and 0) and the i.v. routes (- 3 and -1).
Mice in Groups B and D were also injectedl
s.c. with 106 cultured CCH1 fibrosarcoma
cells on Day -2. All mice were challenged
i.v. on Day 0 with 5 x 104 cultured CCHlI
cells, and the number of tumour nodules
per lung counted 14 days later. The protec-
tion conferred by preinjection of tumour
cells was not overcome by silica treatment.
Pretreatment; A Saline; B Saline plus
tumour; C Silica alone; D Silica plus
tumour.
in eliciting the short-term protective effect
(Fig. 4). Further studies undertaken in
parallel with the above, indicated that the
pre-injection of 0 1 ml of a 10% v/v solu-
tion ofFCS in RPMI medium had no effect
on the growth of tumour cells injected i.v.
2 days later.
Possible mechanisms whereby short-term
protection is achieved
A number of experiments have been
undertaken to help clarify the possible
means whereby protection is conferred in
this short-term pre-treatment model. Al-
though these experiments failed to estab-
lish the precise mechanism involved, they
nevertheless have enabled us to exelude
some ofthe possible explanations original-
ly advanced (James et al., 1978).
In order to assess the possible role of
macrophages we compared the protection
achieved in normal mice and micereceiving
a course ofsilica injections, which is known
to severely impair macrophage function
(e.g. Jones and Castro, 1977). In essence
this involved injecting mice i.p. with 2-5
mg ofsilica in 0 2 mlofphysiological saline,
on Days 4, 2 and 0, relative to i.v.
challenge with tumour cells. Additional
i.v. injections of 2-5 mg of silica were also
given on days -3 and - 1. As indicated
in Fig. 5, this intensive course of silica
treatment failed to influence the protec-
tion due to short-term pre-treatment with
homologous tumour cells. Further studies
revealed that the protection was also not
ablated by treatment with sodium aurio-
thiomalate (1 mg/day on Days 5 to 0)
adding further support to the contention
that the observed effect was not macro-
phage mediated (see Fig. 6).
The possible involvement of T-depen-
dent immune processes in this phenome-
non was investigated in B-cell-deprived
mice. In these experiments, mice which
had been T-cell-depleted as described
earlier were injected s.c. after a 7-8-week
interval with 106 lethally irradiated
(22,000 rad) or untreated cultured CCHIl
tumour cells and challenged i.v. with 106
cultured CCHI tumour cells 2 or 11 days
I _s~
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FIG. 6.-The effect, of sodlium aurothiomalate
treatment on the protection achievedi by
preinjecting tumour cells 2 days before i.v.
challenge. Mice in Groups C and D receivedl
(laily i.p. injection of I mg of sodium auro-
thiomalate on Days -5 to 0. In additioni,
animals in Groups B an(d D were injecte(l s.c.
with 106 culture(d CCH1 fibrosarcoma cells
on Day -2. All mice were challengecd i.v.
with 5 x 104 culture(d CCH1 fibrosarcoma
cells oni Day 0 and the ntumber of ttumour
nolules per lung was counted 14 clays later.
The protective effect, conferred by pre-
injection of tumour cells on Day -2 was
not overcome by sodlium aurothiomalate
treatment. Pretreatment: A No piretreat-
ment; B Tumour alone; C Sodium
aurothiomalate alone; D-Sodium auro-
thiomalate ancd tumour.
later. Similar experimenits were simul-
taneously undertaken in intact or sham-
thymectomized X-irradiated mice. The
number of lung tumour nodules seen 2
weeks after challenge is indicated in Table
II. It will be seen that in T-cell-deprived
mice the s.c. injectionoftumourcellsfailsto
inhibit significantly the growth of tumour
cellsinjected i.v. 2 dayslater.Thiscontrasts
markedly with the effect noted in intact
or sham-thymectomized X-irradiated
mice. It should also be stressed that sero-
logical analyses revealed that the capacity
of the T-depleted mice to mount a 7S
antibody (mercaptoethanol resistant) re-
sponse to sheep erythrocytes was severely
impaired relative to that seen in sham-
thymectomized X-irradiated mice and
intact mice. This confirms the effective-
ness of the T-cell-depletion procedure.
Whilst the above observations revealed
that T cells were involved in short-term
protection, additional studies in cortisone-
treated mice showed that the cortisone-
sensitive T-cell subset did not play a
crucial role (Table III). However, protec-
tion was somewhat impaired (though not
ablated) in mice which had been subjected
to 400 rad whole-body irradiation before
s.c. pre-treatment (Table IV).
It should be noted that throughoutthese
studies the pre-injection of 106 viable syn-
geneic tumour cells almost always pro-
duced tumours with diameters of 10 mm
or more when they were killed 14 days
after i.v. challenge.
DISCUSSION
The present results confirm our initial
observations that the pre-injection of
syngeneic tumour cells into mice shortly
before i.v. challenge with the same tumour
impairs the development of lung tumour
nodules. They also indicate that (a) the
effect is specific and more readily achieved
with sotne tumours than others, (b) cul-
tured tumour cells are more effective than
freshly excised cells at evoking protection
and (c) T-dependent cells, though not
macrophages, play a crucial role in this
phenomenon.
Why this short-term protection can be
readily achieved with the 2 MC-induced
fibrosarcomas and not with the T3 fibro-
sarcoma remains to be established. It may
simply reflect a difference in the immuniz-
ing capacity of the tumours, for the 2 MC
fibrosarcomas are known to be more im-
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TABLE II.-A comparison of the effects ofpretreatment at various times on lung tumour
metastasis in B mice
Immune status
Intact
Sham
thymectomized
and irradiated
Thymectomized
and irradiated
Intact
Day* tumour
cells injected
s.c. Tumour nodules/lung Pt
Not injected 3, 5, 6, 7, 7, 9, 10, 11, 12
-2 0, 0, 0, 1, 1, 2, 4, 4,
-11 0, 0, 0, 0, 0, 0, 0, 0, 0, 2
Not in
Not iI
Not ir
Sham Not in
thymectomized
and irradiated
Thymectomized Not in
and irradiated
<0*01
<0*01
tjected 1, 7, 7, 8, 8, 9, 15, 16, 18, 28
-2 2, 3, 4, 4, 4, 5, 5, 7, 7, 10
*11 0, 0, 0 , 0, 0, 0, 1, 1, 1
ajected 1, 8, 9, 11, 12, 15, 15, 16, 16, 18
-2 1, 1, 3, 3, 3, 3, 7, 9, 14, 19
-11 0, 0, 0, 0, 1, 2, 3, 3, 5, 8, 11
ajected 133, 211, 232, 241, 242, 260, 270, 347, 350, 455
-2 0, 0, 0,00, 0, 1, 1, 198
*11 O, O,0 ,0 , O, 0, O, 1,1
ijected 12, 13, 102, 169, 173, 183, 201, 222, 300
-2 0, 3, 14, 25, 45, 58, 101, 108, 134, 157
11 0, 0, 1, 16, 16, 21, 72, 74, 79, 114
ijected 142, 143, 254, 270, 306, 400, 438
-2 12, 13, 102, 169, 173, 183, 201, 222, 300
11 6, 9, 14, 150, 164, 178, 300, 304, 330, 340
0 02
<001
>0 05
<001
<0*01
<001
0*05
0 05
>0 05
0-10
* The mice were injected s.c. with 106 cultured irradiated (Exp. 1) or unirradiated (Exp. 2) CCH1 tumour
cells either 11 days or 2 days prior to i.v. challenge with 1 x 105 (Exp. 1) or 2 x 105 (Exp. 2) cultured CCHL
tumour cells. The i.v. challenge in all groups were given on the same day.
t All values compared with respective non-pretreated counterparts.
Note that the protection achieved in the pretreated thymectomized group is less marked than that in the
pretreated intact and sham-thymectomized groups.
TABLE III.-Effect ofcortisone acetate (CA)
on the protection conferred by short-term
preinjection oftumour cells*
Exp. Group Treatment
1 A CA alone
B CA+
tumour
cells
2 A CA alone
B CA+
tumour
cells
3 A CA alone
B CA+
tumour
cells
Tumour nodules/
lung
13, 29, 32, 41, 45,
88, 96, 217, 243,
297
0, 0, 0, 17, 23, 24,
28, 30, 35, 88
17, 25, 40, 42, 52
76
0, 0, 0, 0, 0, 10,
15, 26
85, 219, 232, 254,
276, 304, 354, 398,
444, 493
14, 19, 22, 44, 83,
94, 126, 345
* In both groups 2-5 mg of cortisone acetate in
0-2 ml of saline was administered i.p. on Days -3,
-1 and + 1. Group B was also injected s.c. with 106
CCH1 fibrosarcoma cells on Day -2. All mice were
challenged i.v. with 105 CCH1 cells on Day 0, and
the number of tumour nodules counted on Day 14.
In all experiments the preinjection of homologous
tumour cells significantly inhibited the number of
tumour nodules produced by the i.v. injection of
tumour cells
munogenic than the T3 tumour (see Table
I). Furthermore, as the protection elicited
by CCH1 is dose dependent (see James et
al., 1987) it is possible that higher doses
of T3 might have proved effective.
The reason why cultured CCH1 fibro-
sarcoma cells evoke a better protection
than freshly excised cells is still far from
clear. However, it should be noted that
differences in host response to syngeneic
cultured and freshly excised tumour cells
have been noted by others. For example,
recent reports indicate that cultured tu-
mour cells elicit a more rapid infiltration
of host cells than do their freshly excised
counterparts (Moore and Moore, 1977) are
more susceptible to immunological des-
truction in vivo (Pasternack et al., 1978)
and may also generate a more significant
cytotoxic response (Galili et al., 1978). In
addition, in our own laboratory we have
seen differences in the growth rates of
freshly excised and cultured tumours (see
Fig. 3) and in their host immunoglobulin
content (Bessos, Merriman and James,
unpublished observations).
Exp. Group
A
B
C
D
1 E
F
G
H
I
A
B
C
D
2 E
F
G
H
I
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TABLE IV. Effect of prior irradiation
(400 rad) on the protection conferred by
short-term preinjection of tumour cells
Treatment
Tumour Day
cells irradi- Tumour
Exp. Group s.c.* atedt nodules/lung P
1 A No Not 37, 43, 85,131,
irradi- 135, 140, 142, 0-02
ated 160, 163
B Yes 0, 0, 2, 5, 5, 14,
33, 40, 88, 300+
C No -3 63, 240, 300+,
300+, 300+
1) Yes -3 15, 26, 110, -005
138, 183, 195,
202
E No -1 72, 124, 190,
200, 200, 250,
270, 280, 300,+
300+ <0 01
F Yes --1 5, 17, 32, 57,
69, 120, 130,
131, 137, 170
G No + 1 120, 180, 220,
260, 270, 270,
300+, 300+ <0 01
H Yes +1 0, 5, 23, 26,
41, 73, 73, 87,
113, 208
2 A No Not 34, 46, 47, 77,
irradi- 128, 146, 172,
ated 190, 300+ <0 01
B Yes 0,0,0,0,0, 1,
2, 12, 13
C No -3 116, 117, 131,
176, 180, 194,
220, 252 -005
D Yes -3 0, 12, 50, 94,
120, 123, 234,
300(+
E No -1 146, 197, 210,
245, 246, 268,
279, 309 0-02
F Yes -1 0, 0, 0,0, 10,
15, 33, 59, 144
G No +1 86, 103, 146,
158, 180, 193,
205, 206, 278,
278 <0 01
H Yes +1 0, 0, 2, 2, 5,
18, 44, 78, 118
* 106 CCH1 tumour cells injected s.c. 2 days before
i.v. challenge on Day 0 with 105 CCH1 tumour cells.
t Day 400 rad whole-body X-irradiation (thorax
shielded) performed in relationship to i.v. challenge
on Day 0.
Though the protective effect was not ablated by
irradiatioIl, it was less pronounced in animals irra-
diated before s.c. injection of tumour cells.
Initially, we were inclined to the view
that the observed effects were due to in-
herent differences in the antigenicity of
the 2 preparations. One possibility was
that the use of proteolytic enzymes in the
preparation of tumour-cell suspensions
had stripped tumour-specific transplanta-
tion antigens from the cell surface. Al-
though such antigens would eventually be
regenerated after s.c. transplantation, the
delay in their expression would most likely
produce a delay in the stimulation of host
defence mechanisms. Thus, by the time
they were eventually expressed, the i.v.
injected tumour would be irreversibly
established. An alternative explanation is
that the cultured tumour cells had ab-
sorbed foetal-calf serum proteins from the
culture media and these exogenous pro-
teins modulated the immune response. In
this context it is interesting to note that
others have reported that mammalian cells
(Kerbel and Blakeslee, 1976) and virus
(Snyder and Fox, 1978) may absorb foetal
calf serum proteins from culture media.
Such absorbed proteins may evoke a
cellular or humoral response against them-
selves.
The observation that the trypsin or
pronase treatment of cultured cells fails to
modify the protective effect they elicit
suggests, at least indirectly, that the in-
ferior effect offreshly excised cells is prob-
ably not due to the removal of antigens
by these enzymes during cell preparation.
Nevertheless, it must be borne in mind
that deoxyribonuclease treatment was
also used in the preparation of cells from
freshly excised tumours and this could
conceivably have altered the properties of
the cells.
The alternative explanation, that the
effects may be due to foetal-calf serum
proteins absorbed during prolonged cul-
ture, is also unlikely. In the first place, the
protective effect is tumour specific and in
the second, the effect cannot bereproduced
by injecting a relatively large dose of
foetal calf serum 2 days before i.v. chal-
lenge. It is conceivable, however, that
certain foetal-calf serum proteins are in-
tegrated into the tumour-cell surface, and
that their presence augments the immu-
nogenicity of tumour-specific transplanta-
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tion antigens, in the same way that viral
antigens are believed to potentiate the
immune response to weakly immunogenic
tumours (Hellstrom et al., 1978; Kuzamaki
et al., 1-978).
While the above suggestions are of
theoretical interest we feel that the dif-
ferences are most probably due to the
presence in the freshly excised tumour-cell
preparations of host lymphoreticular cells,
which somehow modulate the immune
response to the tumour cells after trans-
plantation into a new host. For example,
in the light of previous observations from
our laboratory on the CCH1. tumour used
in these studies (Szymaniec and James,
1976) it is conceivable that freshly excised
tumour-cell suspension contained suppres-
sor cells (either T cells or macrophages)
which interfered with the developmeent of
prompt and effective anti-tumour immu-
nity. In this context it could be argued
that the superior lung-colonizing proper-
ties of freshly excised tumour, over their
cultured counterparts (see Fig. 3), was due
to the presence of suppressor host cells in
the freshly excised tumour-cell suspension.
It should be noted however that others
have recently shown that differences in
the growth characteristics of freshly ex-
cised and cultured tumouLr cells are related
to their capacity to produce inhibitors of
macrophage chemotaxis (Pasternack et al.,
1978).
An additional possibility is that the
larger tumours which arise after trans-
plantation of freshly excised cells give less
protection due to an "eclipse" phenome-
non. Whatever the explanation for the
differences in host responses to freshly
excised and cultured tumour cells, these
recent observations are undoubtedly of
importance in relation to all studies using
tumour isotransplants, and certainly war-
rant further investigation.
Although the mechanisms by which
short-term protection is achieved still re-
mains to be established, our observations
to date indicate that T-cell-dependent
immune responses are important, and that
macrophages probably play an insignifi-
cant role. Furthermore, the fact that the
effect can be achieved in cortisone acetate-
treated mice suggests that a steroid-
resistant T-cell population is involved,
thus excluding a role for steroid-sensitive
suppressor-cell precursors (Schechter and
Feldman, 1977). Whatever the cells in-
volved, our studies indicate that a radia-
tion-sensitive precursor exists. The mature
effector cells, however, are resistant to low
doses ofX-irradiation. It should bestressed
that the protective effect conferred may
be yet another example of concomitant
immunity. Nevertheless, it is interesting
to note that the protection conferred is not
related to the size ofthe s.c. tumour at the
time of sacrifice, and can be readily
achieved in the absence of a tumour bur-
den, namely after s.e. injection of lethally
irradiated tumour cells (e.g. Table II and
James et al., 1978). In addition it should
be noted that while the s.c. injection of
tumour as late as one day before i.v. chal-
lenge inhibits the growth of lung tumour
nodules, such treatment is ineffective if
delayed until the time of i.v. challenge,
even though there is no detectable differ-
ence in the size of the s.c. tumours when
the animals are killed (see James et al.,
1978). Finally, whilst we have not per-
formed studies to see whether the pre-
injection oftumour cells i.v. can inhibitthe
growth of ttumour cells injected s.c., such
effects have been reported by others
(Yuhas et al., 1975).
Our studies to date do n-ot exclude the
involvement of antibody-mediated pro-
cesses. Among the untested possibilities
are the rapid development of antibodies
which might render the i.v. injected tu-
mours susceptible to either complement-
mediate lysis or antibody-dependent cel-
lular cytotoxicity mechanisms. In this
connection it is interesting to note that
others have observed the rapid appear-
ance, within 2 days of tumour injection,
of humoral factors which are capable of
inducingantibody-dependent cellular cyto-
toxic reactions (Pollack and Nelson, 1975).
Finally, the possibility also exists that pre-
injection of tumour results in the rapid
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appearance of homocytotrophic antibody
which might bind to mast cells inthelungs.
The subsequent injection of tumours
would elicit an immediate hypersensitivity
response, which in some way might inhibit
tumour growth.
In conclusion, the present results clearly
establish that certain tumours rapidly
evoke a specific immune response against
themselves rather than switch off anti-
tumour responses, as has been suggested
by others (see James, 1977). However, the
precise means by which this is achieved
and its relevance to the initial phases of
tumour growth still remains to be estab-
lished.
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